With A/H1N1, A Spectre Is Haunting China: The Spectre Of SARS
This article was originally published in PharmAsia News
Executive Summary
BEIJING - As China's government mulls whether to galvanize a dozen vaccine producers across the country to turn out up to 300 million doses of an A/H1N1 defense and continues with the rapid-fire quarantine of anyone suspected of having contact with swine flu victims, health authorities are meeting with World Health Organization representatives to coordinate closely Beijing's response to the pandemic
You may also be interested in...
China’s Healthcare Reforms A Great Start But Institutional Weakness Could Hamper Progress – The Lancet
China’s biggest weakness is institutional, which makes it difficult for its large and growing healthcare system to be effective, say report authors.
Asia Spotlight: China’s New SFDA Chief Has A Public Health Background, And International Ties
Vice Minister of Health Yin Li assumes post as director of China’s State FDA, taking the reigns from Shao Mingli, who led the agency since 2005.
Meet Yin Li: China’s New SFDA Chief Has A Public Health Background, And International Ties
Vice Minister of Health Yin Li assumes post as director of China’s State FDA, taking reigns from Shao Mingli, who led the agency since 2005.